The Immigration Department will launch new electronic services tomorrow for eligible applicants to complete the entire process of birth or death registrations online, without having to visit a registry in person. According to the Births & Deaths Registration (Amendment) Ordinance 2023, which will take effect tomorrow, the statutory time limit for the registration of deaths from natural causes is extended from 24 hours to 14 days. It also removes the requirement for applicants who need to register births or deaths to attend the registries in person, so as to provide a legal basis for the introduction of electronic services for these kinds of registration. Under the new electronic services, if either parent of a newborn baby is a Hong Kong permanent resident, the parents may submit an application for a birth registration online within 42 days after the birth of their legitimate child. They may apply for a birth certificate at the same time and choose to receive it by
Secretary for Food & Health Prof Sophia Chan said experts of the Joint Scientific Committee under the Centre for Health Protection will monitor the situation of new COVID-19 variants and review the data on the protection of various vaccines against such variants.
Speaking to the media after attending a radio programme today, Prof Chan noted that the committee has given information about the protection of different vaccines against the new variants.
She said: “According to the experts, the BioNtech vaccine is able to protect against some of the variants of concern. For the Sinovac vaccine, they are still waiting for further information from Sinovac.
“The experts will continue to monitor the situation and review any data provided to the Department of Health.”
For the vaccine produced by AstraZeneca, which the Government has signed an advance purchase agreement with, Prof Chan said the Government is aware of the news reports concerning the vaccine in different countries.
“We also notice there is news from the World Health Organization and also some countries most recently said that all the adverse effects are not related to or do not have a direct relationship with the vaccination of the AstraZeneca vaccine.
“We will continue to monitor the situation and the Department of Health has asked the manufacturer for further information.”
She explained that regarding the procedure, the manufacturer must first apply for approval for use in Hong Kong and the Advisory Panel on COVID-19 Vaccines will review the data before it recommends it for authorisation by the Government.
Such a process has not yet started, Prof Chan added.
http://dlvr.it/Rw1Htb
http://dlvr.it/Rw1Htb